scholarly journals Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders

2017 ◽  
Vol 6 (2) ◽  
pp. 14 ◽  
Author(s):  
Lesia Ruglass ◽  
Alina Shevorykin ◽  
Vanja Radoncic ◽  
Kathryn Smith ◽  
Philip Smith ◽  
...  
Keyword(s):  
Substance Use ◽  
Treatment Outcomes ◽  
Substance Use Disorders ◽  
Behavioral Treatment ◽  
Cannabis Use ◽  
Cognitive Behavioral ◽  
Cognitive Behavioral Treatment

scholarly journals Multi-Site Dissemination of Four-Session Individual Transcending Self Therapy: An Integrative Cognitive-Behavioral Therapy for Substance Use Disorders

2021 ◽  
Vol 8 (1) ◽  
pp. 1-10
Author(s):  
Polak K ◽  
Keyword(s):  
Substance Use ◽  
Cognitive Behavioral Therapy ◽  
Substance Use Disorders ◽  
Behavioral Treatment ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Cognitive Behavioral Treatment ◽  
Central Importance

Efficacious interventions for Substance Use Disorders (SUDs) among veterans are of central importance. To address this need, Transcending Self Therapy: Four-Session Individual Integrative Cognitive Behavioral Treatment (Individual-TST-I-CBT) was developed.

Challenges in Assessing and Treating Patients with Body Dysmorphic Disorder and Recommended Approaches

2017 ◽  
Author(s):  
David Veale ◽  
Katharine A Phillips ◽  
Fugen Neziroglu
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Mental Health Treatment ◽  
Behavioral Treatment ◽  
Body Dysmorphic Disorder ◽  
Cognitive Behavioral Treatment ◽  
Appropriate Treatment ◽  
Multiple Challenges ◽  
Suicidal Patients ◽  
Delay In Seeking Treatment

Clinicians commonly encounter multiple challenges when assessing and treating individuals with body dysmorphic disorder (BDD). Some of the major challenges include poor insight and low motivation for appropriate treatment, delay in seeking treatment, desire for usually ineffective cosmetic treatment (e.g., surgery or dermatologic treatment) instead of mental health treatment, co-occurring substance use disorders, and frequent and sometimes severe suicidality. This chapter discusses recommended approaches to these challenges that clinicians can implement when assessing and treating patients with BDD. Strategies for engaging patients in cognitive-behavioral treatment and pharmacotherapy, and for disengaging patients from cosmetic treatment, are reviewed. Suggestions for treating patients with comorbid substance use disorders and suicidal patients are offered.

Self-Stigma and Etiological Attributions About Symptoms Among Individuals Diagnosed With an Anxiety Disorder: Relations With Symptom Severity and Symptom Improvement Following CBT

2018 ◽  
Vol 37 (7) ◽  
pp. 536-557
Author(s):  
Rosemond T. Lorona ◽  
Thomas A. Fergus ◽  
David P. Valentiner ◽  
Lindsay M. Miller ◽  
Patrick B. McGrath
Keyword(s):  
Anxiety Disorder ◽  
Treatment Outcomes ◽  
Symptom Severity ◽  
Behavioral Treatment ◽  
Cognitive Behavioral ◽  
Symptom Improvement ◽  
Cognitive Behavioral Treatment ◽  
Regression Analyses ◽  
The U.S

Nearly one-third of individuals in the U.S. will be diagnosed with an anxiety disorder during their lifetime. Receiving that label can evoke self-stigma, with self-stigma relating to greater symptom severity and negatively impacting treatment outcomes. A lesser-studied variable related to self-stigma is etiological attributions about symptoms, including biological and psychological attributions. The current study examined interrelations among self-stigma, etiological attributions, and symptom severity among 213 individuals diagnosed with an anxiety disorder who completed a cognitive-behavioral treatment (CBT) program. How self-stigma and etiological attributions related to symptom improvement following the program was examined in a subset of participants. Etiological attributions and self-stigma shared positive associations with symptom severity. Regression analyses indicated that, when controlling for overlap among self-stigma and etiological attributions, psychological attributions emerged as particularly relevant for understanding symptom severity. Changes in self-stigma and attributions were positively associated with changes in symptom severity following the CBT program. Study implications are discussed.

Sign in / Sign up

Export Citation Format

Share Document